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hmedss_pharm@yAbstract A new simple spectrophotometric method was developed for the simultaneous determination
of drugs with interfering spectra in binary mixtures without previous separation. The new method is
based on a simple modiﬁcation for the ratio subtraction method. This modiﬁcation enabled wider range
of application. The proposed ratio difference method was applied for the determination of brimonidine
and timolol in laboratory prepared mixtures with mean percentage recoveries 100.4072.29 and
101.2371.30 respectively, and in their pharmaceutical formulation with mean percentage recoveries
101.0870.44 and 100.6670.52 respectively. The suggested ratio difference method was validated
according to USP guidelines and can be applied for routine quality control testing.
& 2012 Xian Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Several manipulations were performed on the raw overlapping
spectral data to enable mixture resolution, for example, using
different order derivatives [1–6], derivatives of the ratio spectrum
[7–10] and ratio subtraction technique [11].rsity. Production and hosting
n Jiaotong University.
.004
46106003.
ahoo.com (A.S. Saad).A new method ratio difference has been developed having
the advantages of minimal data processing and wider range of
application. The method was applied for the analysis of a
mixture of brimonidine tartarate (Br) and timolol maleate (Ti)
recently introduced into the markets.
2. Theory of the ratio difference method
Upon dividing the absorption spectrum of a compound by a
spectrum of the same compound, a straight line of constant
amplitude (parallel to the baseline) will result. However, upon
dividing the absorption spectrum of a compound by the
absorption spectrum of another compound, a new spectrum
(ratio spectrum) will result (Figs. 1 and 2).
Mathematically it can be explained as follows:
In the ratio spectrum of a laboratory mixture of X and Y
divided by a divisor Y0
P1 ¼P1X þ K ð1Þ
P2 ¼P2X þ K ð2Þ
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Figure 1 The ratio spectrum of 20 mg/mL Br (——), 50 mg/mL Ti
(- - -) and a mixture containing 20 mg/mL Br and 50 mg/mL Ti (?)
using a divisor of 50 mg/mL Ti in distilled water.
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Figure 2 The ratio spectrum of 20 mg/mL Br (——), 50 mg/mL Ti
(- - -) and a mixture containing 20 mg/mL Br and 50 mg/mL Ti (?)
using a divisor of 20 mg/mL Br in distilled water.
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Figure 3 The absorption spectra of 20 mg/mL Br (——) and
50 mg/mL Ti (- - -) in distilled water.
Simple spectrophotometric method for simultaneous determination of binary mixtures 383where P1 and P2 are the amplitudes of the mixture spectrum at l1
and l2, respectively. P1X and P2X are the amplitudes of X at l1
and l2, respectively, and K is the constant resulting from Y/Y0.
DP122 ¼P12P2¼ ðP1X þ KÞ2ðP2X þ KÞ ¼P1XP2X ð3Þ
So the component Y will be completely cancelled and the
difference will represent the X component only.
Component X in a binary mixture can be determined from
a calibration curve that relates the difference in amplitudes
(DP12) in the ratio spectrum at l1 and l2 using a certain
concentration of Y as a divisor to the corresponding concen-
tration of X. Similarly component Y can be obtained by using
a certain concentration of X as a divisor.Table 1 Determination of Br and Ti in laboratory
prepared mixtures by the proposed ratio difference method.
Concentration (mg/mL) Recovery (%)
Br Ti Br DP260–290 nm Ti DP295–330 nm
10.00 50.00 96.52 101.06
20.00 20.00 100.75 101.42
20.00 40.00 100.43 102.53
20.00 50.00 100.82 101.23
25.00 30.00 103.33 102.26
30.00 50.00 99.58 98.87
Mean 100.40 101.23
Std 2.29 1.30
RSD 2.28 1.283. Materials and method
SHIMADZU UV-1601 dual beam UV–visible spectrophoto-
meter (Kyoto/Japan), Br and Ti reference standards (kindly
supplied by Sigma Pharmaceutiacal Co. Cairo, Egypt), stock
standard solution of 0.1 mg/mL Br and 0.1 mg/mL Ti in
distilled water.
3.1. Procedures
3.1.1. Construction of calibration curves
The zero order spectra of different solutions of Br and Ti were
divided by the spectra of 50 mg/mL Ti and 20 mg/mL Br,
respectively. The difference in the peak amplitudes DP at the
ratio spectra was measured at 260 and 290 nm (DP260290 nm)for Br and at 295 and 330 nm (DP295330 nm) for Ti. Calibra-
tion graphs relating DP at the chosen wavelength couples to
the corresponding concentrations of Br and Ti were con-
structed, and the corresponding regression equations were
computed.3.1.2. Analysis of laboratory prepared mixtures
The zero order spectra of different laboratory prepared mix-
tures were divided by the spectrum of 50 mg/mL Ti (DP260–290
was recorded) and the spectrum of 20 mg/mL Br (DP295–330 nm
was recorded) for determination of Br and Ti, respectively.3.1.3. Application of the proposed ratio difference method for
the simultaneous determination of Br and Ti in Combigan
ophthalmic solution
0.5 mL of the solution was transferred to another 100 mL
measuring ﬂask, and the volume was completed with distilled
water. The concentrations of Br and Ti were obtained as in
Section 3.1.2.4. Results and discussion
The proposed ratio difference method can be applied for
resolving absorption spectra of two components with high
degree of overlap as in the case of Br and Ti (Fig. 3), where the
application of the direct spectrophotometry failed to deter-
mine either of them in their mixture.
Table 2 Determination of Br and Ti in Combigans eye drops by the proposed ratio difference method and application of
standard addition technique.
Product in
Combigans
eye dropa
Standard addition Recovery (mean7SD, %)
Taken (mg/mL) Added (mg/mL) Found (mg/mL) Recovery (%) Proposed method Standard addition
Br 10.00 5.00 4.93 98.60 101.0870.44 100.1071.41
10.00 10.14 101.40
20.00 20.06 100.30
Ti 25.00 20.00 20.15 100.75 100.6670.52 100.4270.68
25.00 24.91 99.64
30.00 30.26 100.87
aCombigans eye drops, batch no. E62201 labeled to contain 2 mg/mL of brimonidine tartarate and 5 mg/mL of timolol.
Table 3 Assay validation sheet of the proposed ratio
difference method for the determination of Br and Ti.
Parameter Br Ti
Accuracy (mean7SD) 100.1671.32 100.1771.66
Speciﬁcity 100.4072.29 101.2371.30
Precision
Repeatabilitya 100.2170.73 100.0670.32
Intermediate precisionb 100.0770.40 100.0970.39
Linearity
Slope 0.0762 0.0811
Intercept 0.1105 0.0780
Correlation coefﬁcient r 0.9999 0.9998
Range (mg/mL) 5–30 10–60
aThe intraday (n¼3), average of three concentrations (10, 15
and 20 mg/mL) for Br and (20, 30 and 40 mg/mL) for Ti
repeated three times within the day.
bThe interday (n¼3), average of three concentrations (10, 15
and 20 mg/mL) for Br and (20, 30 and 40 mg/mL) for Ti
repeated three times on three consecutive days.
E.S. Elzanfaly et al.384The method comprises two critical steps, the ﬁrst is the
choice of the divisors, the selected divisors should compromise
between minimal noise and maximum sensitivity. The divisor
concentrations 50 mg/mL Ti and 20 mg/mL Br gave the best
results regarding the average percentage recovery when used
for the prediction of Br and Ti concentrations, respectively.
The second critical step is the choice of the wavelengths at
which measurements are recorded. Any two wavelengths can
be chosen provided that they exhibit different amplitudes in
the ratio spectrum and a good linearity is present at each
wavelength individually.
Linear correlation was obtained between the differences in
amplitude at 260 and 290 nm (DP260–290 nm) for Br and at 295
and 330 nm (DP295–330 nm) for Ti, against the corresponding
concentrations of Br and Ti, respectively.
The proposed ratio difference method was applied for the
determination of brimonidine and timolol in laboratory pre-
pared mixtures (Table 1), and in their pharmaceutical formula-
tions (Table 2). The suggested ratio difference method was
validated according to USP guidelines [12] and can be applied
for routine quality control testing, as shown in Table 3.The suggested ratio difference method showed a wider
range of application over the ratio subtraction method; it
was able to determine both components in the binary mixture
without limitations, whereas the ratio subtraction method [11]
failed to determine the component with the more extended
spectrum (Br in this case).
Regarding simplicity, the proposed ratio difference method
showed minimal data manipulation; instead of applying a
certain order derivative in the derivative ratio method [7–10]
or subtraction of a constant and re-multiplication by the
divisor in the ratio subtraction method, simply the following
step will be calculating DP at any two wavelengths in the ratio
spectrum.Appendix A. Supplementary information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.jpha.2012.04.004.References
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